ATP5F1A antibody: A304-939A


Antibody Info
Product_IDA304-939A
Lot_ID1
Host_organismrabbit
SourceBethyl Labs
Antibody_DCC_IDENCAB205IOV
Target Info
GeneNameATP5A1
Phosphate
Target_nameATP5A1-human
Antibody Info
Product_IDA304-939A
Lot_ID1
Host_organismrabbit
SourceBethyl Labs
Antibody_DCC_ID
Target Info
GeneNameATP5F1A
Phosphate
Target_nameATP5F1A-human

Validation Images
Cell linePrimary validationSecondary validation
HepG2 ATP5A1-HEPG2-CRISPR-A304-939A.png<br>Caption: Western blot following CRISPR against ATP5A1 in HepG2 whole cell lysate using ATP5A1 specific antibody. Lane 1 is a ladder, lane 2 is HepG2 non-targeting control knockdown, lane 3 and 4 are two different CRISPR against ATP5A1. ATP5A1 protein appears as the green arrow, GAPDH serves as a control and appears in red arrow.

Caption: Western blot following CRISPR against ATP5A1 in HepG2 whole cell lysate using ATP5A1 specific antibody. Lane 1 is a ladder, lane 2 is HepG2 non-targeting control knockdown, lane 3 and 4 are two different CRISPR against ATP5A1. ATP5A1 protein appears as the green arrow, GAPDH serves as a control and appears in red arrow.

Releated Sample: BGHcLV29-9

Status: Released

Lab: Graveley Lab

K562 Bethyl_A304-939A_1_ATP5A1.png<br>Caption: IP-WB analysis of K562 whole cell lysate using the ATP5A1 specific antibody, A304-939A. Lanes 1 and 2 are 2.5% of five million whole cell lysate input and 50% of IP enrichment, respectively, using a normal IgG antibody. Lane 3 is 50% of IP enrichment from five million whole cell lysate using the ATP5A1-specific antibody, A304-939A. The same antibody was used to detect protein levels via Western blot. This antibody passes preliminary validation and will be further pursued for secondary validation. *NOTE* Protein sizes are taken from Genecards.org and are only estimates based on sequence. Actual protein size may differ based on protein characteristics and electrophoresis method used.

Caption: IP-WB analysis of K562 whole cell lysate using the ATP5A1 specific antibody, A304-939A. Lanes 1 and 2 are 2.5% of five million whole cell lysate input and 50% of IP enrichment, respectively, using a normal IgG antibody. Lane 3 is 50% of IP enrichment from five million whole cell lysate using the ATP5A1-specific antibody, A304-939A. The same antibody was used to detect protein levels via Western blot. This antibody passes preliminary validation and will be further pursued for secondary validation. *NOTE* Protein sizes are taken from Genecards.org and are only estimates based on sequence. Actual protein size may differ based on protein characteristics and electrophoresis method used.

Method: immunoprecipitation

Status: Released

Lab: Yeo Lab

Cell linePrimary validationSecondary validation
K562 ATP5A1-K562-CRISPR-A304-939A.png<br>Caption: Western blot following CRISPR against ATP5F1A in K562 whole cell lysate using ATP5F1A specific antibody. Lane 1 is a ladder, lane 2 is K562 non-targeting control knockdown, lane 3 and 4 are two different CRISPR against ATP5F1A. ATP5F1A protein appears as the green arrow, GAPDH serves as a control and appears in red arrow.

Caption: Western blot following CRISPR against ATP5F1A in K562 whole cell lysate using ATP5F1A specific antibody. Lane 1 is a ladder, lane 2 is K562 non-targeting control knockdown, lane 3 and 4 are two different CRISPR against ATP5F1A. ATP5F1A protein appears as the green arrow, GAPDH serves as a control and appears in red arrow.

Releated Sample: BGKcLV26-37

Status: Experimented

Lab: Graveley Lab